↓ Skip to main content

Dove Medical Press

Article Metrics

Aripiprazole: from pharmacological profile to clinical use

Overview of attention for article published in Neuropsychiatric Disease and Treatment, October 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)

Mentioned by

twitter
3 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
121 Mendeley
Title
Aripiprazole: from pharmacological profile to clinical use
Published in
Neuropsychiatric Disease and Treatment, October 2015
DOI 10.2147/ndt.s88117
Pubmed ID
Authors

Marco Andrea Riva, Guido Di Sciascio

Abstract

Clinical experience with aripiprazole has confirmed the effectiveness and the safety of this novel antipsychotic drug in patients with schizophrenia as well as for the treatment of mania in type I bipolar disorder. However the generalization of the results from clinical trials requires further effort in order to address some issues and to overcome incorrect and partial interpretation of the clinical evidence. This article provides some straightforward guidance that may help clinical psychiatrists to translate the mechanism of action of aripiprazole into clinical setting, thus improving the appropriate use of the drug through rational application of its pharmacological profile. Examples of paradigmatic clinical situations are presented and discussed, suggesting possible intervention strategies, which may contribute to achieving the most appropriate use of the pharmacological properties of aripiprazole in real life settings.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 121 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 25 21%
Student > Master 15 12%
Student > Ph. D. Student 12 10%
Researcher 10 8%
Other 9 7%
Other 23 19%
Unknown 27 22%
Readers by discipline Count As %
Medicine and Dentistry 25 21%
Pharmacology, Toxicology and Pharmaceutical Science 14 12%
Psychology 12 10%
Neuroscience 11 9%
Agricultural and Biological Sciences 9 7%
Other 18 15%
Unknown 32 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 October 2015.
All research outputs
#8,185,581
of 14,535,828 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,078
of 2,442 outputs
Outputs of similar age
#108,388
of 253,809 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#54
of 84 outputs
Altmetric has tracked 14,535,828 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,442 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 253,809 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.